(Q54438493)

29 May 2018

title

Pancreatic cancer in the general population: Improvements in survival over the last decade. (English)

1 reference

29 May 2018

1 reference

6

Courtney M Townsend

1 reference

29 May 2018

author name string

Taylor S Riall

1

1 reference

29 May 2018

William H Nealon

2

1 reference

29 May 2018

James S Goodwin

3

1 reference

29 May 2018

Dong Zhang

4

1 reference

29 May 2018

Yong-Fang Kuo

5

1 reference

29 May 2018

Jean L Freeman

7

1 reference

29 May 2018

publication date

1 November 2006

1 reference

29 May 2018

Journal of Gastrointestinal Surgery

published in

1 reference

29 May 2018

volume

10

1 reference

29 May 2018

issue

9

1 reference

29 May 2018

page(s)

1212-23; discussion 1223-4

1 reference

29 May 2018

Periampullary adenocarcinoma: analysis of 5-year survivors

cites work

1 reference

12 December 2020

Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297.

1 reference

12 December 2020

Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization

1 reference

12 December 2020

The advantages of bypass operations over radical pancreatoduodenectomy in the treatment of pancreatic carcinoma.

1 reference

12 December 2020

Frequency with which surgeons undertake pancreaticoduodenectomy determines length of stay, hospital charges, and in-hospital mortality

1 reference

12 December 2020

Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up

1 reference

12 December 2020

Adenocarcinoma of the body and tail of the pancreas: is there room for adjuvant radiotherapy?

1 reference

12 December 2020

Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma--part 3: update on 5-year survival

1 reference

12 December 2020

The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer

1 reference

12 December 2020

Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality

1 reference

12 December 2020

Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection

1 reference

12 December 2020

Locally advanced pancreatic cancer treated with radiation and 5-fluorouracil: a first step to neoadjuvant treatment?

1 reference

12 December 2020

The Effects of Regionalization on Cost and Outcome for One General High-Risk Surgical Procedure

1 reference

12 December 2020

Effect of hospital volume and experience on in-hospital mortality for pancreaticoduodenectomy

1 reference

12 December 2020

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators

1 reference

12 December 2020

Treatment of Locally Advanced Pancreatic Cancer in the Real World: Population-Based Practices and Effectiveness

1 reference

12 December 2020

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

1 reference

12 December 2020

Is extended resection for adenocarcinoma of the body or tail of the pancreas justified?

1 reference

12 December 2020

1 reference

12 December 2020

Carcinoma of the body and tail of the pancreas: is curative resection justified?

1 reference

12 December 2020

Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes

1 reference

12 December 2020

Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume

1 reference

12 December 2020

Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC).

1 reference

12 December 2020

Prognostic indicators for survival after resection of pancreatic adenocarcinoma.

1 reference

12 December 2020

Gemcitabine combined with docetaxel for the treatment of unresectable pancreatic carcinoma

1 reference

12 December 2020

Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors

1 reference

12 December 2020

Adenocarcinoma of the pancreas: a statistical analysis of biliary bypass vs Whipple resection in good risk patients

1 reference

12 December 2020

Management of adenocarcinoma of the body and tail of the pancreas

1 reference

12 December 2020

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

1 reference

12 December 2020

A combination of a fixed dose rate infusion of gemcitabine associated to a bolus 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).

1 reference

12 December 2020

Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States).

1 reference

12 December 2020

Effect of hospital volume on in-hospital mortality with pancreaticoduodenectomy.

1 reference

12 December 2020

Importance of hospital volume in the overall management of pancreatic cancer.

1 reference

12 December 2020

One hundred and forty-five consecutive pancreaticoduodenectomies without mortality

1 reference

12 December 2020

10.1016/J.GASSUR.2006.08.010

Identifiers

DOI

1 reference

29 May 2018

Dimensions Publication ID

1039396385

0 references

1 reference

29 May 2018